Cytosolic phospholipase A2alpha contributes to blood pressure increases and endothelial dysfunction under chronic NO inhibition.

scientific article published on 24 February 2011

Cytosolic phospholipase A2alpha contributes to blood pressure increases and endothelial dysfunction under chronic NO inhibition. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/ATVBAHA.110.218370
P698PubMed publication ID21350197

P2093author name stringTakao Shimizu
Ichiro Hisatome
Kohei Tanaka
Naonori Uozumi
Motoaki Saito
Yasutaka Yamamoto
Kazuhide Ogino
Shunsuke Tsujimoto
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)1133-1138
P577publication date2011-02-24
P1433published inArteriosclerosis, Thrombosis, and Vascular BiologyQ4797542
P1476titleCytosolic phospholipase A2alpha contributes to blood pressure increases and endothelial dysfunction under chronic NO inhibition.
P478volume31

Reverse relations

cites work (P2860)
Q47681288Bone marrow-derived cPLA2α contributes to renal fibrosis progression.
Q47859985Brain Cytosolic Phospholipase A2α Mediates Angiotensin II-Induced Hypertension and Reactive Oxygen Species Production in Male Mice
Q35175554Cytosolic phospholipase A2α is critical for angiotensin II-induced hypertension and associated cardiovascular pathophysiology
Q35886245Cytosolic phospholipase A₂: physiological function and role in disease
Q39364189Integrated investigation of lipidome and related signaling pathways uncovers molecular mechanisms of tetramethylpyrazine and butylidenephthalide protecting endothelial cells under oxidative stress
Q47565244[Carboxyl-11 C]Labelling of Four High-Affinity cPLA2α Inhibitors and Their Evaluation as Radioligands in Mice by Positron Emission Tomography.
Q34171442iPLA2β overexpression in smooth muscle exacerbates angiotensin II-induced hypertension and vascular remodeling

Search more.